Title: Immune-checkpoint inhibitor therapy is underutilized in the US: A multi-institutional cohort analysis

Immunol Lett. 2022 Apr:244:43-44. doi: 10.1016/j.imlet.2021.12.005. Epub 2021 Dec 30.

Authors

Nicholas Theodosakis¹, Pearl Ugwu-Dike², Vartan Pahalyants³, Kerry Reynolds¹, Yevgeniy Semenov¹

Affiliations

¹ Massachusetts General Hospital, Department of Dermatology, Boston, MA, US.
² Massachusetts General Hospital, Department of Dermatology, Boston, MA, US. Electronic address: pugwu-dike@mgh.harvard.edu.
³ Brigham and Women's Hospital, Department of Medicine, Boston, MA.

PMID: 34974035
DOI: 10.1016/j.imlet.2021.12.005

No abstract available

Publication types

Letter

MeSH terms

Cohort Studies
Humans
Immune Checkpoint Inhibitors* / therapeutic use
Retrospective Studies

Substances

Immune Checkpoint Inhibitors